In the latest installment of our “A Life in Science” series, Audrey Clapéron, Translational Biology Director, discusses the crucial role of data in advancing discovery. Leading a team of pharmacologists and supplying high-quality evidence for clinical development keeps her driven and connected to potential patients who may benefit in the future.
“Data are clearly at the basis of everything. They provide evidence for decision-making in an objective way, and so they are very important for the project,” says Audrey Clapéron, Translational Biology Director at Ipsen.
Her work focuses on ensuring that projects are guided by trustworthy results. “My everyday life is to make sure that all the pharmacological data are provided to the project. I’m also leading a team of in-vivo and in-vitro pharmacologists.”
These data are not just abstract but crucial for progressing discoveries. “We are very close to the patient because we are providing evidence and data for clinical development, and so the patients are almost right here.”
This proximity to patients influences how Audrey and her team approach challenges. “When things get complex and challenging, I always come back to the key priorities for the project—to provide new, innovative medicine to the patients, make some prioritization if needed, communicate with the team, and provide a vision so they can work efficiently for the project to move forward.”
Audrey’s perspective emphasizes that data are more than just information—they are the proof that enables medications to advance, always with patients in mind.
/2026/03/16/maxstockworld478883-69b84d5397581001737640.jpg "The diocese of Saint")
